Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

CRM

Salesforce launches $25B share repurchase program

Salesforce (NYSE: CRM) has initiated its largest-ever $25 billion accelerated share repurchase (ASR) program, reflecting the company's confidence in its future. This ASR represents the immediate execution of half of the $50 billion aggregate share repurchase program authorized by Salesforce’s board of directors in February 2026.

The company has entered into ASR agreements with Banco Santander, S.A., Bank of America, N.A., Citibank, N.A., JPMorgan Chase Bank, National Association, and Morgan Stanley & Co. LLC, with J. Wood Capital Advisors LLC serving as an advisor.

The initial delivery of approximately 103 million shares represents about 80% of the total shares anticipated to be repurchased, based on the closing price of Salesforce’s common stock on March 11, 2026.

The final number of shares to be repurchased will be determined by the volume-weighted average price of Salesforce’s common stock during the term of the transaction, less a discount and subject to adjustments. Final settlement is expected to occur in the third or fourth quarter of Salesforce’s FY27.

This historic transaction underlines the leadership’s confidence in the company’s position and its commitment to driving shareholder value. Salesforce's Chair and CEO, Marc Benioff, emphasized the company's aggressive share repurchase strategy as a signal of their confidence in the future. Robin Washington, President and Chief Operating and Financial Officer of Salesforce, also expressed increased conviction in the durability of the company's growth and cash flow trajectory.

This move will be closely watched by investors and analysts as they gauge the impact of this significant share repurchase on Salesforce’s financial position and shareholder value. Today the company's shares have moved -2.75% to a price of $227.11. For the full picture, make sure to review Salesforce's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS